China (Mainland)
7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one CAS NO.199327-61-2
- Min.Order: 1 Kilogram
- Payment Terms: L/C,D/A,D/P,T/T
- Product Details
Keywords
- 199327-61-2 manufacturer
- Gefitinib intermediate
- 7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one
Quick Details
- ProName: 7-Methoxy-6-(3-morpholin-4-ylpropoxy)q...
- CasNo: 199327-61-2
- Molecular Formula: C16H21N3O4
- Appearance: white to off-white powder.
- Application: Gefitinib intermediate
- DeliveryTime: prompt at sight of payment or order.
- PackAge: 25kg/drum,or as per customer’s require...
- Port: Any Chinese port.
- ProductionCapacity: 1000 Kilogram/Month
- Purity: 99%
- Storage: Store in a clean, cool, dry area; keep...
- Transportation: Room temperature.
- LimitNum: 1 Kilogram
- Moisture Content: ≤1.0 %
- Impurity: ≤0.5 %
- Residue on ignition: ≤0.5%
Superiority
Hangzhou Fortune Biopharm Co.,Ltd.is a private-owned company which is initially dedicated to R&D of Active pharmaceutical ingredients and intermediates.
Our main products include:
Acetazolamide,Aminocaproic Acid,Aripiprazole,Butaphosphan,Dorzolamide HCL,Fluorometholone,Fosfomycin calcium,Ketotifen fumarate,Tetrahydrozoline HCl,Tinidazole,etc.
We admire science and technology as our principle for development, we regard the quality of our products as the life of the whole enterprise.
We could guarantee:
1.High quality
2.Competitive price in the global market
3.Prompt delivery
4.Technical support
5.Documents support
Details
|
Product Name: |
7-Methoxy-6-(3-morpholin-4-ylpropoxy)quinazolin-4(3H)-one |
|
Synonyms: |
7-Methoxy-6-(3-Morpholin-4-ylpropoxy) Quinazolin- 4-(3H)-One Gefitinib HCL InterMediates G5;Getitinib interMediate;Gefitinib iMpurity F;Gefitinib Impurity 14;Gefitinib Impurity 8;7-methoxy-6-(3-morpholin-4-ylpropoxy)-1H-quinazolin-4-one;7-Methoxy-6-(3-morpholin-4-ylpropoxy)quainazolin-4(3H)-one;6-(3-morpholinopropoxy)-7-methoxyquinazolin-4(3H)-one |
|
CAS: |
199327-61-2 |
|
MF: |
C16H21N3O4 |
|
MW: |
319.36 |
|
EINECS: |
1308068-626-2 |
|
Assay: |
≥99.0% |
|
Application: |
Gefitinib intermediate |